Evelo Biosciences is discovering and developing therapies designed to engage immune cells in the small intestine to drive therapeutic immune effects throughout the body for the treatment of inflammatory diseases and cancers. The company is developing monoclonal microbials, a modality of oral biologic medicines. The company initiates a clinical trial of its monoclonal microbial candidate in inflammatory diseases, EDP1066 and initiates a clinical trial for its inflammation candidate, EDP1815. The company is developing monoclonal microbial therapies in oncology. The company initiates its clinical trial of its oncology product candidate, EDP1503 in combination with KEYTRUDA? (pembrolizumab) in various oncology indications.
PFSweb is a provider of omni-channel commerce solutions, including a range of technology, infrastructure and other services. The company's service offerings include website design, creation and integration, digital agency and marketing, eCommerce technologies, order management, customer care, logistics and fulfillment, financial management and consulting. The services the company provides are primarily organized into the following categories: Strategic Commerce Consulting Services; Design and Digital Marketing Services; Technology Services; Order to Cash; Fulfillment; and Customer Care.
Insiderinsights' advanced insider analytics combine statistical track records with numerous behavioral metrics to rate the significance of a firm's insider trading history in real time.
Academic studies and the experience of professionals back the common sense conclusion that the Form 4 data filed daily at the SEC is a profitable data stream to mine for investment intelligence. But most investors use commodity insider feeds that are full of noise and time-consuming to analyze, or ratings services that employ last century's simplistic insider scoring methodology.
InsiderInsights compiles Daily, Weekly, and Monthly reports that list US equities with recent insider activity, along with proprietary Company Ratings clearly indicating the Significance Level of insider sentiment. Our monthly Special Screens further combine our Ratings with various fundamental and price action criteria, to highlight the best value, growth, momentum, and short ideas coming from the executive suite.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.